🔎 Trials Near Me

Почетна › Вилмов тумор › Тексас

Kliničke studije za Вилмов тумор u državi Тексас

6 studija za Вилмов тумор traži učesnike na lokacijama u državi Тексас.

Gradovi u državi Тексас

Zvanični tekst studije (na engleskom)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Тражи се учесникФаза 2
Узраст од 12 до 39 · Оба пола · Ажурирано 12. 11. 2026. · NCT04616560

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

  • Cook Children's Health Care System (Data Collection Only), Fort Worth
Тражи се учесникФаза 2
12 Months · Оба пола · Ажурирано 23. 10. 2026. · NCT05985161

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • Dell Children's Medical Center of Central Texas, Austin
  • Driscoll Children's Hospital, Corpus Christi
  • Medical City Dallas Hospital, Dallas
  • и још 10
Тражи се учесникФаза 2
До 30 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04322318

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

  • Texas Children's Hospital, Houston
Тражи се учесникФаза 1
Узраст од 1 до 21 · Оба пола · Ажурирано 6. 8. 2026. · NCT04715191

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

  • Houston Methodist Hospital, Houston
Тражи се учесникФаза 1
До 21 година · Оба пола · Ажурирано 3. 11. 2025. · NCT06198296

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.